Health
Combination of SFRP2 and PD-1 immunotherapy halts aggressive metastatic cancer in preclinical model – News-Medical.Net
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist…
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist Nancy Klauber-DeMore, M.D., is pioneering new discoveries.
Using a combination of personal passion and expertise, Klauber-DeMore…
Continue Reading
-
General22 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
General19 hours agoHome of Andrii Yermak, Zelenskyy’s chief of staff, raided by anti-corruption unit
-
General9 hours agoProtecting victims of explicit AI content online
-
General11 hours agoTrolls stole Dr Juliet Turner’s joy and in doing so took their own